Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. | VP, PAO and Interim PFO | Common Stock | 49K | $1.23M | $25.00 | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NTLA | Intellia Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | VP, PAO and Interim PFO |
NTLA | Intellia Therapeutics, Inc. | Apr 10, 2024 | 0 | $0 | 3 | Apr 22, 2024 | Principal Accounting Officer |